LONDON--(BUSINESS WIRE)--As a part of its new healthcare provider analytics article series, Quantzig, a premier analytics services provider, today announced the completion of its recent case study – ‘Analyzing the Role of Pharmacovigilance Analytics for German Precision Medicine Market'
The case study also offers comprehensive insights on:
- The benefits of pharma pharmacovigilance analytics
- How pharmacovigilance helps in tracking complexities around drug development
Gain new insights and identify opportunities to gain a leading edge in the precision medicine market by getting in touch with an analytics expert. For immediate, comprehensive industry insights speak to our analytics experts.
Pharmacovigilance analytics broadly describes the process of leveraging advanced analytics to collect, analyze, and interpret complex datasets containing drug safety information to identify hidden patterns and unknown correlations that can help companies operating in the precision medicine market to make better decisions.
At Quantzig, we analyze the current business scenario using real-time dashboards to help global enterprises operate more efficiently. Our ability to help performance-driven organizations realize their strategic and operational goals within a short span using data-driven insights has helped us gain a leading edge in the analytics industry. To help businesses ensure business continuity amid the crisis, we’ve curated a portfolio of advanced healthcare provider analytics solutions that not just focus on improving profitability but help enhance stakeholder value, boost customer satisfaction, and help achieve financial objectives.
Want comprehensive solution insights from an expert who decodes data? You’re just a click away! Request a FREE demo to discover how our seasoned analytics experts can help you.
“Considering the growing complexities around drug development and drug safety, pharmacovigilance departments within the precision medicine market must have in place a robust process to identify risks and extract product & indication-specific information from across the organization,” says a pharmacovigilance analytics expert at Quantzig.
Quantzig’s pharmacovigilance analytics solutions also empowered the client to:
- Reduce preparation time for drug safety reviews from days to hours
- Understand safety risks earlier in the drug development phase
- Maintain good relationships with regulators
- Enhance the protection of patients through
The pharmacovigilance analytics experts at Quantzig adopted a comprehensive three-phased approach that focused on expanding the drug development and safety monitoring initiative beyond case processing to include the data from aggregated precision medicine market reports. Gain new insights and identify opportunities to gain a leading edge in the precision medicine market by getting in touch with a pharmacovigilance analytics expert. Request FREE proposal to know more.
Quantzig’s Healthcare Analytics Capabilities Include:
- Clinical trial reporting and analytics
- Pharmacovigilance analytics
- Drug pricing and promotion analytics
- Patient analytics
To know more about our healthcare provider analytics solutions, visit: https://bit.ly/2WpiPkN
Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal